DCLA
BHC icon

Douglas C. Lane & Associates’s Bausch Health BHC Stock Holding History

Douglas C. Lane & Associates’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,469
Closed -$262K – 224
2015
Q3 		$262K Buy
+1,469
New +$343K 0.01% 205

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Douglas C. Lane & Associates's BHC Position: Q4 2015 in Review

Douglas C. Lane & Associates sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 1,469 shares — an estimated $262K sold.

Douglas C. Lane & Associates first reported a position in BHC in Q3 2015 and held it in 1 quarter. The position peaked at $262K in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Douglas C. Lane & Associates reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Douglas C. Lane & Associates sold 1,469 Bausch Health shares in Q4 2015, an estimated $262K.
  • Douglas C. Lane & Associates first reported a position in Bausch Health in Q3 2015 and held it in 1 quarter.
  • Douglas C. Lane & Associates's Bausch Health position peaked at $262K in Q3 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.